Anika Wilson
Psychiatry · Madison, ALNPI 1306055330
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,589 of the $15,258 with a category attached, or 89.1%. It is spread thinly across 31 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 828 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Corium, LLC$1K
- Otsuka America Pharmaceutical, Inc.$870
- Tris Pharma Inc$775
- plus $6K from 25 others
What the payments were for
- Speaking & faculty fees$1,3209%
- Travel & lodging$3452%
- Food & beverage$13,58989%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 184 | $3,265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $2,016 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 109 | $1,591 |
| Corium, LLC | 83 | $1,165 |
| Otsuka America Pharmaceutical, Inc. | 48 | $870 |
| Tris Pharma Inc | 48 | $775 |
| Ironshore Pharmaceuticals Inc. | 57 | $743 |
| Alkermes, Inc. | 35 | $630 |
| Axsome Therapeutics, Inc. | 30 | $571 |
| Neos Therapeutics, LP | 35 | $524 |
| Sunovion Pharmaceuticals Inc. | 41 | $475 |
| Lundbeck LLC | 30 | $468 |
| Supernus Pharmaceuticals, Inc. | 26 | $432 |
| Johnson & Johnson | 17 | $418 |
| Vanda Pharmaceuticals Inc. | 13 | $270 |
| Neuronetics, Inc. | 10 | $238 |
| Idorsia Pharmaceuticals US Inc | 5 | $178 |
| Adlon Therapeutics L.p. | 10 | $161 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Vertical Pharmaceuticals, LLC | 3 | $59 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Bausch Health US, LLC | 2 | $32 |
| Shire North American Group Inc | 2 | $28 |
| Rhodes Pharmaceuticals L.p. | 2 | $28 |
| Sage Therapeutics, LLC | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $21 |
| Noven Pharmaceuticals, Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Almatica Pharma LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$1,665
- VRAYLAR$353
- REXULTI$250
- CAPLYTA$225
- SPRAVATO$131
- Azstarys$123
- QUVIVIQ$110
- Auvelity$110
- NEUROSTAR TMS THERAPY$103
How this compares
$15,258 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 26 | $174 |
| Risperidone | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Madison
- Ammar AlrefaiMadison$16K
- Justin ParrottMadison$14K
- Daniel LaeuppleMadison$7K
- Jun LiuMadison$7K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
- Scariya KumaramangalamHuntsville$440K
- Mark HaygoodMobile$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.